CDH2 and cancer: The ability of cancer cells to migrate and invade has long been associated with the ability of cells to undergo epithelial–mesenchymal transition (EMT), in which cells go from a structural phenotype associated with high levels of E-cadherin, to a more migratory and invasive one, in which N-cadherin is upregulated [27].